Vivanza Biosci. — 360° view

Vivanza Biosci, a company in the Pharmaceuticals industry, reported revenue of ₹11 crore and net profit of ₹0.14 crore for the September 2026 quarter.

Vivanza Biosci. (BSE: VIVANZA) closed at ₹1.66 on 20 Nov 2026, down 22.4% over the past year. Its market capitalisation is ₹7 crore and it trades at 166.0 times earnings.

Share price
₹1.66 (20 Nov 2026)
Market cap
₹7 Cr (20 Nov 2026)
P/E
166.00 (20 Nov 2026)
Revenue
₹11 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
6.11% (FY26)
ROE
9.38% (FY26)
Book value
₹1.16 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹2.46 / ₹1.30 (20 Nov 2026)
1-year return
-22.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: VIVANZA

Incorporated in 2016, Vivanza Biosciences Ltd is in the business of providing medicines and healthcare solutions

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.